Oncorus, Inc., a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that its President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will present at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, December 4, 2019 at 8:30 a.m. ET.
About Oncorus
At Oncorus, we are driving innovation to deliver next-generation viral immunotherapies to transform outcomes for cancer patients. We are advancing a portfolio of intratumorally and intravenously administered viral immunotherapies for multiple indications with significant unmet needs based on our oncolytic herpes simplex virus-1 and synthetic virus platforms. Our team has engineered proprietary, multidimensional innovations into both platforms to enable us to deliver on the full potential of this therapeutic class to dramatically improve outcomes for cancer patients. Please visit www.oncorus.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005405/en/
Contacts:
